medullary thyroid cancer and glp-1 GLP-1RA initiation linked to new diagnoses GLP-1 analogues do not increase
Description
Methods We conducted a systematic review of studies from PubMed, Embase, and Cochrane databases (until November 2024), as well as relevant abstracts from Digestive Disease Week (DDW) 2024 and American College of Gastroenterology (ACG) 2024 to assess the impact of GLP-1 receptor agonists (GLP-1 RAs) on EGD
Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related cancers, especially colorectal cancer, according to data released on Thursday ahead of a major medical meeting.
Combining herbal supplements like moringa with GLP-1 medications requires careful consideration
Some even suggest that GLP-1 agonists might have the potential to supplant MASH therapy in its entirety
